• Fucoidan’s Caveolin-1 Modulation: A New Pathway in Cancer Re

  2026-06-04

  Explore how Fucoidan, a sulfated α-L-fucan, targets caveolin-1 to suppress breast cancer progression and enhance immune response. This in-depth article reveals mechanisms and protocol strategies distinct from current content, positioning Fucoidan as a next-generation anticancer polysaccharide.

• 4-Hydroxytamoxifen: Technical Use and Protocol Parameters

  2026-06-03

  4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator optimized for DMSO-based workflows in breast and prostate cancer research, apoptosis assays, and cardiac myocyte studies. It is unsuitable for protocols requiring aqueous or ethanol solubility. Researchers should adhere to strict solubilization and storage protocols to maintain integrity and reproducibility.

• iRhom2 Modulates Olfactory Receptor Dynamics in Sensory Neur

  2026-06-03

  The referenced study uncovers a previously unrecognized role for iRhom2 in regulating olfactory receptor (OR) expression and sensory adaptation in mouse olfactory sensory neurons. By linking odor-induced activity to iRhom2/ADAM17 signaling, the research provides new mechanistic insight into feedback regulation within the olfactory system with implications for sensory plasticity and receptor repertoire control.

• AMPK Modulation of Mitophagy and Inflammation in Diabetic Pe

  2026-06-02

  This study demonstrates that AMPK activation in periodontal ligament fibroblasts can resolve inflammation by enhancing PINK1/Parkin-mediated mitophagy, even under diabetic and mechanical loading conditions. These findings reveal a mechanistic link between mitochondrial quality control and inflammatory responses, suggesting new strategies to protect periodontal tissue in metabolic disease contexts.

• Chloroquine (BA1002): Practical Guidance for Research Use

  2026-06-02

  Chloroquine (N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine) is a well-characterized anti-inflammatory agent for malaria and rheumatoid arthritis research, also applied in autophagy and antiviral studies. This article provides actionable setup, handling, and troubleshooting parameters for controlled laboratory applications. Use is not recommended where water solubility is required or clinical safety monitoring cannot be ensured.

• Innovative CEC Approach to β2-Adrenergic Binding Constant An

  2026-06-01

  This study introduces an open-tubular capillary electrochromatography (CEC) method with part-coating columns for precise determination of binding constants between β2-adrenergic receptors and key cardiovascular drugs, including norepinephrine bitartrate. The approach reduces protein consumption and enhances throughput, providing reliable affinity data crucial for drug screening and adrenergic receptor research.

• Hepatic sEH–Nrf2 Pathway: A Key Regulator in Osteoclastogene

  2026-06-01

  A recent study reveals that hepatic soluble epoxide hydrolase (sEH) drives osteoclast differentiation in osteoporosis by suppressing the Nrf2 antioxidant pathway, establishing a liver-bone axis for redox control. These insights offer new directions for signaling pathway modulation and potential therapeutic targeting in bone metabolic disease.

• ARCA-Capped mRNA Synthesis: Bridging Discovery to Immunother

  2026-05-31

  This thought-leadership article explores the mechanistic and strategic importance of ARCA-capped, polyadenylated mRNA in translational research, with a focus on innovative immunotherapy platforms such as mRNA nanovaccines for hepatocellular carcinoma. By dissecting the workflow advantages of the HyperScribe™ Co-transcription mRNA Synthesis Kit Plus, the article provides actionable guidance for researchers aiming to accelerate RNA-based therapeutic development while contextualizing recent breakthroughs and outlining future directions.

• HATU in Translational Peptide Synthesis: Mechanism to Impact

  2026-05-30

  Explore how HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) catalyzes a new era in translational peptide chemistry, bridging mechanistic excellence with real-world strategy for next-generation inhibitor design.

• HDAC Inhibitors Suppress NUT Carcinoma by Targeting NUT Func

  2026-05-29

  This study presents a high-throughput chemical screen that identifies diverse histone deacetylase (HDAC) inhibitors, including panobinostat and novel molecules, as potent repressors of NUT function in NUT carcinoma. The findings clarify the mechanisms by which HDAC inhibition disrupts oncogenic megadomains and transcriptional programs, offering new avenues for targeted therapy in this aggressive cancer.

• Innovative CEC Approach to β2-Adrenergic Receptor Binding An

  2026-05-29

  This study presents a novel open-tubular capillary electrochromatography method for determining binding constants between β2-adrenergic receptors and various drugs, including norepinephrine bitartrate. The technique reduces protein consumption and enhances binding affinity analysis, offering practical advantages for drug-receptor interaction studies and lead compound screening.

• GSK343: Translational Epigenetic Tool for Functional Genomic

  2026-05-28

  Discover how GSK343, a potent EZH2 inhibitor, empowers functional genomics and advanced epigenetic cancer research. This article provides unique insights into assay design and translational strategy, bridging recent findings in chromatin regulation with practical experimental workflows.

• Mitoxantrone HCl (SKU B2114): Reliable Assay Performance in

  2026-05-28

  This article demonstrates how Mitoxantrone HCl (SKU B2114) addresses key laboratory challenges in cell viability, apoptosis, and cytotoxicity assays. By leveraging scenario-driven Q&A and validated protocols, biomedical researchers can ensure experimental reproducibility and mechanistic insight using this DNA topoisomerase II inhibitor. The discussion emphasizes practical advantages, workflow compatibility, and data-backed reliability.

• Fosinopril Sodium: Applied Protocols in ACE Inhibitor Resear

  2026-05-27

  Fosinopril sodium stands out as a phosphinic acid ACE inhibitor uniquely suited for translational hypertension and cardiovascular disease models. This guide delivers actionable workflows, troubleshooting strategies, and comparative insights for researchers aiming to optimize blood pressure modulation and renal hemodynamics studies.

• Tacalcitol Monohydrate: Precision Modulation in Disease Mode

  2026-05-27

  Explore Tacalcitol monohydrate, a synthetic analog of vitamin D3, as a precision tool for dissecting gene regulation and cellular pathways in disease models. This article delivers new insights into its mechanistic specificity and experimental optimization, setting it apart from previous reviews.

407 records 13/28 page Previous Next First page 上5页 1112131415 下5页 Last page